How to Cite
Abstract
Abnormal uterine bleeding (AUB) is a frequent reason for gynecological consultation due to its high incidence, which affects the quality of life of many women. In general terms, AUB is any bleeding of gynecological origin that presents abnormalities in its frequency, intensity or volume, which can have short, medium or long term consequences. According to its etiology it can be subdivided into two groupings, structural and non-structural (PALM-COEIN), this classification provides us with the facility in epidemiological research, understand the etiology and provide the optimal management, which should be personalized, the latter is divided into hormonal and non-hormonal treatment.
Keywords
References
Côté I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol [Internet]. 2003;188(2):343–8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12592237/
Franco R. Hemorragia uterina anormal orgánica. Revista Nacional de Itaguá. 2012;4(2):15-22. Disponible en: http://scielo.iics.una.py/pdf/hn/v4n2/v4n2a03.pdf
Milman N, Clausen J, Byg KE. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol [Internet]. 77(1–2):13–9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9760147/
Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand [Internet]. 45(3):320–51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/5922481/
Sepúlveda J, Sepúlveda A. Sangrado utrerino anormal y PALM COEIN. Revista de ginecología y obstetricia México. 2020;88(1):59-67. Recuperado a partir de: https://www.medigraphic.com/pdfs/ginobsmex/go m-2020/gom201j.pdf
Sun Y, Wang Y, Mao L, Wen J, Bai W. Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study. Medicine (Baltimore) [Internet]. 2018];97(31):e11457. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30075511/
Hassa H, Tekin B, Senses T, Kaya M, Karatas A. Are the site, diameter, and number of endometrial polyps related with symptomatology? Am J Obstet Gynecol [Internet]. 2006;194(3):718–21. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16522403/
Lee SC, Kaunitz AM, Sanchez-Ramos L, Rhatigan RM. The oncogenic potential of endometrial polyps: a systematic review and meta-analysis. Obstet Gynecol [Internet]. 2010 116(5):1197–205. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20966706/
Vigueras A, Escalona J. Pólipos endometriales: Actualización en diagnóstico y tratamiento. Rev Chilena de Obstetricia y Ginecología. 2016;81(2):152-158. Disponible en: http://dx.doi.org/10.4067/S0717- 75262016000200012.
Levgur M. Diagnosis of adenomyosis: a review. J Reprod Med [Internet]. 2007;52(3):177–93. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17465285/
Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol [Internet]. 2017;40:68–81. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27810281/
Brun J, Fenomanana S, Pelage L, Fernández H. Adenomiosis: tratamiento. EMC- Ginecología- Obstetricia. 2015;51(3):1-10. Disponible en: https://www.sciencedirect.com/science/article/abs /pii/S1283081X1572833
Alfonso C. Leiomiomas uterinos e infertilidad. Sección de biología de la Universidad de la Laguna. 2019;1(1):1:27. Disponible en: https://riull.ull.es/xmlui/bitstream/handle/915/1575 2/Leiomiomas%20uterinos%20e%20infertilidad.p df?sequence=1
Lasmar RB, Lasmar BP. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB). Best Pract Res Clin Obstet Gynaecol [Internet]. 2017;40:82–8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27784616/
Styer AK, Rueda BR. The epidemiology and genetics of uterine leiomyoma. Best Pract Res Clin Obstet Gynaecol [Internet]. 2016;34:3–12. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26725703/
Emons G, Beckmann MW, Schmidt D, Mallmann P, Uterus commission of the Gynecological Oncology Working Group (AGO). New WHO classification of endometrial hyperplasias. Geburtshilfe Frauenheilkd [Internet]. 2015 75(2):135–6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25797956/
Adams T, Denny L. Abnormal vaginal bleeding in women with gynaecological malignancies. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 134-47. doi: 10.1016/j.bpo- bgyn.2016.09.014
Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG [Internet]. 2004;111(7):734–40. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15198765/
Fuentes A, Castillo Z, Aragón J. Sangrado uterino anormal (y endocrinológico). Revista de endocrinología y nutrición. 2005;13(1):39-46. Disponible en: https://www.medigraphic.com/pdfs/endoc/er- 2005/er051f.pdf
Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. BJOG [Internet].;88(4):434–42. Disponible en: http://dx.doi.org/10.1111/j.1471-0528.1981.tb01009.x
Benetti-Pinto C, Rosa-e-Silva A, Yela D, Soares Júnior J. Abnormal Uterine Bleeding. Rev Bras Ginecol Obstet [Internet]. 2017 39(07):358–68. Disponible en: http://www.thieme- connect.de/DOI/DOI?10.1055/s-0037-1603807
Chacón Campos N, Pizarro Madrigal M, Guerrero Hines C. Sangrado uterino anormal en etapa reproductiva. Rev Medica Sinerg [Internet]. 2022;7(5):e808. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/808
Zurita G, Bravo E. Sangrado uterino anormal de origen no anatómico en mujeres en edades entre 15 a 50 años. Universidad Católica de Ecuador. 2017;1(1):1-104. Recuperado a partir de: http://repositorio.puce.edu.ec/bitstream/handle/22 000/13279/ADAPTACION%20GUIA%20DE%20 PRACTICA%20CLINICA%20SANGRADO%20U TERINO%20ANORMAL.pdf?sequence=1&isAllo wed=y
Lee JY, Hahn PM, Van Dijk JP, Reid RL. Treatment of menorrhagia with tranexamic acid. J SOGC [Internet]. 2000;22(10):794–8. Disponible en: https://www.sciencedirect.com/science/article/pii/S0849583116310199
Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ [Internet] ;313(7057):579–82. Disponible en: https://pubmed.ncbi.nlm.nih.gov/8806245/
Bofill M, Lethaby A, Farquhar C. Non-steroidal anti-inflam- matory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;9(9):CD000400. https://pubmed.ncbi.nlm.nih.gov/31535715/
Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial: A randomized controlled trial. Obstet Gynecol [Internet]. 2006;108(4):924–9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17012455/
Vega G, Bautista L, Rodríguez L, Loredo F, Vega J, Becerril A, et al. Frecuencia y factores asociados a la histerectomía obstétrica en un hospital de segundo nivel en México. Rev chilena de Obstetricia y Ginecología. 2017;82(5):526-533. Recuperado a partir de: https://scielo.conicyt.cl/scielo.php?pid=S0717- 75262017000500526&script=sci_arttext&tlng=n
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 Array